NBD peptide

• Description:

  NBD peptide inhibits NF-κB signaling pathway through inhibition of the NEMO-IKK complex combination. NBD peptide exhibits anti-inflammatory efficacy through block of pro-inflammatory cytokines production. NBD peptide exhibits immunosuppressive activity through regulation of immune cells. NBD peptide enhances its transmembrane ability by combining with cell-penetrating peptide HIV-TAT[1].

• UNSPSC:

  12352209

• Target:

  NF-κB

• Related Pathways:

  NF-κB

• Field of Research:

  Inflammation/Immunology

• Smiles:

  O=C (N[C@@H] (C) C (N[C@@H] (CC (C) C) C (N[C@@H] (CC (O) =O) C (N[C@@H] (CC1=CNC2=CC=CC=C12) C (N[C@@H] (CO) C (N[C@@H] (CC3=CNC4=CC=CC=C34) C (N[C@@H] (CC (C) C) C (N[C@@H] (CCC (N) =O) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CCC (O) =O) C (O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) [C@H] ([C@H] (O) C) N

• Molecular Formula:

  C62H88N14O20

• Molecular Weight:

  1349.44

• References & Citations:

  [1]Zhou CL, et al., The latest developments in synthetic peptides with immunoregulatory activities. Peptides. 2011 Feb;32 (2) :408-14.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  371915-62-7